From the best mentors and experts in the business
Your peers in Australia’s largest deep tech community
Your business, team and customer base
Your seed or series A round with VC funds and angels
Cicada Innovations is proud to be called home to Australia's rising medtech startups.
Trimph is an injectable and regenerative scaffold to repair damaged bone cartilage and skin without the need for invasive surgery and has raised over $4M from public grants and private investment.
Botox-maker Allergan acquired Elastagen, a clinical stage company developing medical device products based on recombinant tropoelastin, for $340 million.
SpeeDx has developed world-leading diagnostics for genetic mutations in cancer cells, as well as a range of STIs. Head-quartered at Cicada, SpeedX now has offices in London and US and distributors across Europe.
Prospection is a leading health insights company providing rich technical and data analytical capabilities to over 50 healthcare clients from government to pharma, hospitals and researchers.